Search

Home > GRACEcast Lung Cancer Video > Rociletinib/Osimertinib for EGFR T790M-negative NSCLC
Podcast: GRACEcast Lung Cancer Video
Episode:

Rociletinib/Osimertinib for EGFR T790M-negative NSCLC
Category: Science & Medicine
Duration: 00:05:20
Publish Date: 2016-04-20 16:57:50
Description:

Dr. Jack West, Swedish Cancer Institute, reviews trial evidence for the efficacy of rociletinib and osimertinib for EGFR acquired resistance not driven by a T790M mutation.
Total Play: 0